Monalisa is an injectable dermal filler line and consists of 4 different variations, Soft, Mild, Hard, and Ultra. Monalisa is based on cross-linked hyaluronic acid and contains lidocaine. The manufacturer of Monalisa, Genoss, has developed a cross-linking technique called Hy-BRID. This technique enables the production of highly dense and uniform particles that gives the dermal fillers a high viscoelasticity for greater volume and durability. The product is maintained for at least 6 months before the dissolution process begins.
Furthermore, the risk of an allergic reaction and edema is minimal due to the crosslinking technique of Hy-BRID that significantly reduces the BDDE residues and has shown levels that are below what regulations require. Monalisa was CE-certified in 2010.
Each letter represents an important stage in the manufacturing process.
Based on non-animal HA
Improved Density and elasticity